According to a statement on November 14 by the innovative phar (00399.HK), the board of directors will hold a meeting on Friday, November 29, 2024, to consider and approve the consolidated interim results for the six months ended September 30, 2024, for the company and its subsidiaries.
领航医药生物科技(00399.HK)将于11月29日召开董事会会议以审批中期业绩
Innovative phar (00399.HK) will hold a board of directors meeting on November 29 to approve the mid-term performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated